{"task_id": "d91d995dca2857d6", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 905/905)", "text": "V\nSE: constipation; headache\nCI: long QT syndrome.\n\n--- Page 911 ---\nDrug\nDose and frequency\nNotes\nAcute asthma/COPD\nSalbutamol\n5mg via nebulizer as required \naccording to clinical response\nOxygen-driven nebulizer in \nasthma, air-driven in COPD with \nappropriate concentration of \noxygen provided in addition.\nSE: tachycardia; hypokalaemia. \nIpratropium \nbromide\n500mcg/4\u20136h via nebulizer\nSE: GI disturbance, cough.\nPrednisolone \n30\u201350mg/24h (refer to local \nguidelines). \nOral steroids are as eff ective \nas IV. Specify course length.\nSE: DM; peptic ulceration; psy-\nchosis; \ue000BP; \ufb02 uid retention.\nAntihistamines\nChlorphena-\nmine\n4mg/4\u20136h PO\nIn anaphylaxis: 10mg IM\nSE: drowsiness; urinary reten-\ntion; dry mouth; blurred vision; \nGI disturbance.\nCetirizine\n10mg/24h PO\nLoratidine\n10mg/24h PO\nGastric acid-reducing drugs\nRanitidine\n150mg/12h PO or 50mg/8h IV\nSE: diarrhoea; dizziness; \ncholestasis.\nOmeprazole\n20\u201340mg/24h PO or 40mg/24h IV\nSE: GI disturbance; hyper-\nsensitivity.\n\ue007 May mask symptoms of \ngastric cancer.\nLansoprazole\n15\u201330mg/24h PO\nPantoprazole\n20\u201340mg/24h PO or 40mg/24h IV\nHeparins (refer to local guidelines)\nUnfractionated \nheparin\nDVT prophylaxis: \n5000U/8\u201312h SC\nDose needs correcting for \nrenal function and pregnancy \n(see local guidelines).\nSE: bleeding; throm-\nbocytopenia (watch for \ue001 by \n30% or thrombosis 5\u201310 days \ninto treatment); hyperkalae-\nmia; osteo porosis after pro-\nlonged use (\ue001risk with LMWH).\nCI: heparin-induced thrombo-\ncytopenia; bleeding disorders; \nepidural anaesthesia, recent \ncerebral bleed; recent trauma \nor surgery; active bleeding.\nEnoxaparin\nDVT prophylaxis:\n20\u201340mg/24h SC\nDVT/PE treatment:\n1.5mg/kg/24h SC\nTinzaparin\nDVT prophylaxis:\n3500U/24h SC\nDVT/PE treatment:\n175U/kg per 24h SC\nDalteparin\nDVT prophylaxis: \n2500\u20135000U/24h SC \nDVT/PE treatment:\n200U/kg/d SC\nTranquillizers for non-psychotic behavioural disturbance\nLorazepam\n1\u20132mg PO/IM\nDe-escalation techniques \n\ufb01 rst. Medication only to \ue001risk \nof harm to self/others. \ue000Risk \nof medication in frail, elderly, \ncomorbid conditions. Wait 60 \nmin for response. Seek expert \nhelp if needs repeat dose.\nSE: respiratory depression; \ndrowsiness; ataxia; confusion; GI \ndisturbance; urinary retention.\nCI: respiratory disease\nSee also: prescribing in palliative care (pp532\u2013537), laxatives (p260), inhalers (p183), \ndigoxin (p115), insulin (p589), \ufb02 uid (p666), oxygen prescribing (p189), naloxone (p842).", "text_length": 2409, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 905/905)", "type": "chunk", "chunk_index": 904, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.743409", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.744356", "status": "complete", "chunks_added": 2}